RESOURCE
We demonstrate the versatility of a collection of insertions of the transposon Minos-mediated integration cassette (mimIC), in Drosophila melanogaster. mimIC contains a gene-trap cassette and the yellow + marker flanked by two inverted bacteriophage ΦC31 integrase attP sites. mimIC integrates almost at random in the genome to create sites for dna manipulation. the attP sites allow the replacement of the intervening sequence of the transposon with any other sequence through recombinase-mediated cassette exchange (RmCE). We can revert insertions that function as gene traps and cause mutant phenotypes to revert to wild type by RmCE and modify insertions to control GaL4 or QF overexpression systems or perform lineage analysis using the Flp recombinase system. Insertions in coding introns can be exchanged with protein-tag cassettes to create fusion proteins to follow protein expression and perform biochemical experiments. the applications of mimIC vastly extend the D. melanogaster toolkit.
Different types of transposons have been used to manipulate the Drosophila genome and to assess the function of genes, but each is designed for a specific purpose, and none are truly multifaceted. The most commonly used transposons are the P element, piggyBac and Minos [1] [2] [3] . P elements mobilize efficiently and often excise imprecisely, but they exhibit a strong insertional bias for the 5′ ends of genes 4, 5 . piggyBac elements have much less bias 5 but mobilize less efficiently than P elements and only excise precisely 6 . Minos elements have very little insertional bias 5, 7, 8 , transpose stably and efficiently in many organisms 9 , and excise imprecisely at a useful frequency 6, 8 .
The most popular application of transposons is to create mutations directly by insertion or by imprecise excision 10 . Transposons have been engineered to allow controlled misexpression of genes via upstream activating sequence (UAS) sites in the transposon vector 4, 11 or to promote activation of reporters such as GAL4 or β-galactosidase via nearby enhancers 12, 13 . Transposons can also function as gene traps if they carry a splice acceptor site followed mimIC: a highly versatile transposon insertion resource for engineering Drosophila melanogaster genes by stop codons in all three reading frames and a polyadenylation site so that intronic insertions can interrupt transcription and translation 14 . Transposons containing a protein trap harbor a splice acceptor site followed by a coding sequence tag and a splice donor site. When the protein trap is inserted in a coding intron in the appropriate orientation and reading frame, it reveals the protein's expression pattern 15, 16 . Unfortunately, the frequency of P-element insertions in introns is low 4, 5, 17 , and only one-sixth of insertions in introns have the appropriate orientation and reading frame to function as protein traps. Hence, only about 2.5% of Drosophila genes have been tagged with a protein trap, even when a piggyBac having a lesser insertional bias had been used 18, 19 . Each different application of transposons requires the generation and maintenance of thousands of single-insertion stocks. The burden of stock keeping has limited the availability of these different tools: less than 5% of the transposon stocks that have been generated in the past 25 years are still available 5 . For the vast majority of Drosophila genes, only one type of transposon insertion is still available.
Transposons can be engineered to include target sequences recognized by recombinases or integrases 3,20,21 such as Flp recombinase 22 and ΦC31 integrase 23, 24 , respectively. These enzymes can replace sequences in transposons via recombinase-mediated cassette exchange (RMCE) 25, 26 . RMCE has been demonstrated in Drosophila with both Flp recombinase and ΦC31 integrase 27, 28 . ΦC31 integrase is the preferred enzyme because of its higher efficiency in transgenesis and unidirectional integration 23, 24 .
Here we describe a new mutagenesis and genome-manipulation system called Minos-mediated integration cassette (MiMIC). MiMIC is a Minos transposon that carries a dominant marker and a gene-trap cassette flanked by two inverted ΦC31 integrase attP sites. This transposon combines unbiased insertional mutagenesis with the ability to replace the gene-trap cassette by RMCE. Using MiMIC insertions, virtually limitless gene modification and genome engineering can be performed. We illustrate the utility of this system in gene-and protein-trap experiments, and reversion of lethal phenotypes.
(63%) mapped within 1,541 annotated genes, and 72% of these intragenic insertions mapped within introns, including 5′ UTR introns and coding introns, both of which are valuable targets for RMCE-based gene manipulation (Supplementary Table 2 ). We deposited 1,269 selected insertion lines in the Bloomington Drosophila Stock Center (BDSC) as part of the Drosophila Gene Disruption Project (GDP) collection 5 . We will regularly select additional MiMIC lines for the GDP collection and aim to deposit over 6,000 lines during the next 4 years. The GDP maintains an online database (http://flypush.imgen.bcm.tmc.edu/pscreen/) of lines that are available from the BDSC as well as lines that we are still balancing, which may be obtained directly from the GDP.
mimIC insertion mutants can be reverted by RmCE
The MiMIC transposon contains a gene-trap cassette. Hence, insertions in coding introns should truncate transcripts if MiMIC is inserted in the proper orientation. We selected four MiMIC transposons inserted in the proper orientation to be mutator gene traps (cassettes were named as Mi{MIC} followed by the gene name and insertion strain number): Mi{MIC}Rfx MI00053 , Mi{MIC}tutl MI00290 , Mi{MIC}comm MI00380 and Mi{MIC}wnd MI00494 inserted in Rfx, tutl, comm and wnd, respectively. All four alleles were associated with a lethal phenotype. In three cases, the insertion did not complement previously reported mutations of these genes (Supplementary Table 3) , indicating that the lethality was indeed associated with the insertion. Mi{MIC}wnd MI00494 was the exception, but complementation data indicate that Mi{MIC}wnd MI00494 and the previously reported alleles 31 all contained second-site mutations responsible for the lethality, and that none of the transheterozygous wnd allelic combinations caused lethality. For Mi{MIC}Rfx MI00053 , complementation data indicate the presence of uncoordinated escapers for all allelic combinations, a phenotype that has been previously described for Rfx loss-of-function mutations 32 .
We then removed the gene-trap cassette from Mi{MIC}Rfx MI00053 , Mi{MIC}tutl MI00290 and Mi{MIC}comm MI00380 by RMCE with a correction plasmid ( Fig. 1b) , screened for loss of yellow + (Supplementary  Fig. 1 ) and established that the lethality reverted. Hence, intronic MiMIC insertions are mutagenic, and the mutation can be reverted through microinjection of a plasmid. This demonstrates , two inverted ΦC31 integrase attP sites (P), a gene-trap cassette consisting of a splice acceptor site (SA) followed by stop codons in all three reading frames and the EGFP coding sequence with a polyadenylation signal (pA), and the yellow + marker. The sequence between the attP sites can be replaced via RMCE with a plasmid containing two inverted attB sites (B), resulting in two attR sites (R). (b) Three attB plasmids for RMCE: a correction plasmid consisting of a multiple cloning site, a gene-trap plasmid consisting of an SA fused to a downstream effector, and a protein-trap plasmid consisting of a reporter flanked by SA and splice donor site (SD). (c) Various MiMIC insertions in a hypothetical gene with a regulatory element (white), 5′ and 3′ untranslated regions (gray), and coding regions (black) that can be used for several applications as indicated.
that MiMIC is the cause of the lethal phenotypes in these insertion alleles.
Binary expression and lineage analysis with mimIC
A substantial portion (20.4%) of intragenic MiMICs were localized to 5′ UTR introns (Supplementary Table 2 ). Introduction of exogenous protein-coding sequences into these insertions allows expression under control of the endogenous gene regulatory elements. Hence, we constructed three genetrap plasmids that encode GAL4, QF and Flp ( Fig. 2a) . We selected five 5′ UTR intronic insertions: MI00314 and Mi{MIC}BM-40-SPARC MI00329 , inserted in gogo, Tl, caps, MYPT-75D and BM-40-SPARC, respectively. We used RMCE to incorporate each of the three gene-trap cassettes into these insertions.
We tested the GAL4 insertions using a 10×UAS-mCherry cytoplasmic reporter, which comprises 10 copies of the UAS fused to mCherry (Online Methods), the QF insertions with a 5×QUAS-mtdTomato-3×HA membrane reporter containing three hemagglutinin (HA) tags 30 , and the Flp insertions with an act>y+>GAL4;UAS-GFP (> indicates FRT site) cytoplasmic Flpout detector (Online Methods). GAL4 incorporated into the gogo insertion revealed expression in the embryonic peripheral and central nervous system, in agreement with RNA in situ hybridization data (Fig. 2b,c) (T. Suzuki, personal communication). GAL4 inserted into caps recapitulated the known expression pattern 33 (Fig. 2d,e ). The unknown expression pattern of MYPT-75D was revealed by GAL4, QF and Flp integrated in Mi{MIC}MYPT-75D MI00314 . GAL4 analysis revealed many scattered cells labeled during germ-band extension ( Fig. 2f) , some of which appeared to be muscle precursors. QF analysis also revealed this expression pattern ( Fig. 2g ) but resulted in stronger labeling owing to the membrane marker driven by QUAS elements instead of the cytoplasmic marker driven by UAS elements. Flp-out analysis revealed a much smaller subset of labeled cells, suggesting inefficient Flp-out (data not shown). Finally, GAL4 integrated in BM40-SPARC revealed an expression pattern very similar to that revealed by antibodies to the endogenous protein, including expression in hemocytes and fat body ( Fig. 2h) 34, 35 . (GGS) 4 (GGS) 4 We performed PCR analysis to confirm the molecular nature of RMCE events. In each case, PCR demonstrated that a productive binary activation or recombination activity occured only when the cassette was integrated in the appropriate orientation for expression of the reporter (Supplementary Fig. 2) . As RMCE can occur in either orientation, we expected a 50% chance of a productive exchange. However, only 25% of the gene-trap RMCE events were in the productive orientation for expression ( Supplementary  Table 4 ). Although we do not understand the cause, this suggests selection against productive reporter expression.
Protein trapping with mimIC insertions
To determine the expression pattern of the protein product of a gene, including its subcellular localization, one can analyze it after tagging the protein with an epitope to which antibodies are available or by live imaging. More than 51% of intragenic MiMIC insertions are in coding introns and permit protein trapping (Supplementary Table 2 ). We constructed protein-trap cassette plasmids with splice acceptor and splice donor sites flanking synthetic exons encoding protein tags in three versions (Fig. 3a,b and Supplementary Fig. 3 ) so as to convert any MiMIC insertion in a coding intron, regardless of its orientation or splicing phase (0, 1 or 2), into a protein trap. We flanked the sequence encoding a protein tag on both sides with a linker sequence encoding a quadruple Gly-Gly-Ser repeat to increase flexibility between the tag and the host protein. We engineered seven multi-tag cassettes for different applications. Most consisted of a fluorescent tag and a peptide tag so that if in vivo fluorescence imaging was not possible because of low expression, the tag could still be detected using antibodies. In a first protein-trapping test, we introduced the EGFP-FlAsH-StrepII-3×Flag multi-tag in all three phases into Mi{MIC}CadN MI00393 , which we inserted into a phase 0 intron of CadN (Fig. 3c) and used PCR to identify integration events for each orientation and phase. As expected, only the phase 0 cassette integrated in the correct orientation recapitulated the expected expression pattern, and none of the other five classes of events resulted in detectable expression ( Fig. 3d) .
Protein expression analysis with multi-tag cassettes
Next, we evaluated expression patterns using seven different tags in six different genes in which MiMIC inserted in a coding intron: MI00393 and MI{MIC}wnd MI00494 inserted in Rfx (phase 1), tutl (phase 1), rhea (also known as talin) (phase 0), comm (phase 1), CadN (phase 0) and wnd (phase 2), respectively. We introduced the seven different tag cassettes with the proper intron phase into each of the six insertions (Fig. 3a,b and Table 1 ). Then we used PCR to determine the orientation of each RMCE event and established that 48% of the integration events were in the desired orientation. This was in agreement with the 50% frequency expected by chance, suggesting that these events are not detrimental to host gene function. The lethality associated with each of the original gene-trap insertions often reverted upon RMCE with proteintrap tags. For Rfx and tutl, the lethality of the MiMIC gene trap reverted in 69% and 86% of the protein-trap lines, respectively ( Table 1) . This demonstrates that in most cases protein function was at least partially restored when the gene trap was removed and replaced by a protein trap. The reverted lines may be partial loss-of-function mutations or full revertants. Note that reversion of lethality did not occur in most RMCE events for the insertions in comm (15%) or wnd (9%).
Failure to revert the lethality of a MiMIC insertion by RMCE with a protein-trap cassette may result from the effect of the tags on protein function. Alternatively, some of the MiMICbearing chromosomes may contain second-site lethal mutations as previously observed in P-element stocks exposed to transposase 13 , or mutations could be induced during the RMCE procedure because ΦC31 integrase has been shown to induce DNA damage and chromosome rearrangements [36] [37] [38] . Both issues can be obviated by removing the second-site mutations by recombination. To test these possibilities, we crossed protein-trap alleles generated by RMCE that did not revert the lethality of the gene-traps in comm (6 lines), wnd (4 lines), rhea (6 lines) and CadN (4 lines) to previously described alleles and deficiencies uncovering the corresponding loci. All of the protein-trap alleles of all the genes tested complemented the established lethal allele or deletion chromosome, providing evidence that the tagged fusion proteins indeed supply sufficient gene function to revert the lethality.
To determine the expression pattern and subcellular localization of the tagged proteins generated by RMCE, we first stained a large sample of tagged proteins using antibodies to GFP, V5 epitope, monomeric (m)Cherry and Dendra. We compared the expression of the same protein fused to different tags. Detection of CadN with EGFP-FlAsH-StrepII-3xFlag, EBFP2-3xMyc or Dendra-V5 multitags (Fig. 3b) shows very similar expression patterns (Fig. 4a-c) . Similarly, different tag-coding genes integrated into Rfx and tutl showed highly reproducible expression patterns ( Fig. 4d-i) . In the case of rhea, protein trapping allowed live imaging of three different fluorescent tags ( Fig. 4j-l) . The observed expression patterns faithfully recapitulated the previously described expression patterns of CadN 39 , Rfx 40 , tutl 41 and rhea 42 . To determine in more detail whether the fusion protein expression patterns faithfully report the cellular and subcellular localization of the endogenous proteins, we performed simultaneous labeling experiments with antibodies to different tags and the endogenous protein for Rfx and CadN (Fig. 4m-r) . These experiments showed fully overlapping expression patterns in trans-heterozygotes that expressed both the tagged and the untagged proteins.
In total, we tested 166 independent tagged fusion proteins generated by RMCE for six MiMIC insertions and observed that less than 3% (5/166) exhibited a different expression pattern than we anticipated. The different expression patterns were not associated with any particular gene or tag, suggesting that they were due to a faulty RMCE event, and we confirmed this by an aberrant PCR pattern. These data indicate that RMCE-based protein-trapping results in the precise incorporation of tags and will permit the determination of the expression pattern and subcellular distribution of many uncharacterized proteins.
detection of new expression patterns
When analyzing the expression patterns of the different tag sequences integrated into Mi{MIC}wnd MI00494 , we observed an expression pattern that was much broader and more complex than anticipated (Fig. 4s-x and Supplementary Fig. 4) . Antibody staining 31 showed weak expression of Wnd in the embryonic nervous system in stage 16 embryos but not in other tissues (Fig. 4u,x) . However, the Wnd fusion protein generated by RMCE had a very complex and dynamic expression pattern (Fig. 4s,v) and agreed with the pattern revealed by RNA in situ hybridization (Fig. 4t,w) . These and many other immunohistochemical staining experiments on the 166 tagged proteins (data not shown) revealed that well-characterized antibodies to tags that are integrated in fusion proteins were often superior to custom antibodies to the endogenous protein.
dISCUSSIOn
MiMIC-mediated insertions in 5′ UTR introns allow the expression of transcription factors such as GAL4 and QF, and recombinases such as Flp to generate gene-specific binary expression and recombination systems, respectively. Moreover, these insertions allow any current or future effector to be placed under the control of the endogenous gene's regulatory elements. Genes that are tagged by insertions in coding introns can be manipulated in many ways. One can determine gene expression and subcellular protein distribution using light microscopy and likely immunoelectron microscopy 43 . Tags inserted in transcription factors can be used for chromatin immunoprecipitation 44 . Other applications such as combined immunoprecipitation followed by mass spectrometry and identification of RNA binding partners can also be performed. A complementary in vivo swapping approach has been developed recently for enhancer trapping 45 .
The widespread adoption of the MiMIC system by the Drosophila research community will depend on substantially increasing the number of insertion lines that are available for public distribution. Currently, 1,269 unique MiMIC insertions are available from the BDSC, and we are balancing and validating by resequencing about 900 more. In the GDP, we plan to generate ~6,000 additional insertions during the next four years. As Minos integrates almost at random in the genome 5, 8 and about 33% of MiMIC insertions are in coding introns (Supplementary Table 2) , the manipulations documented here will become feasible for many more Drosophila genes. The ability to assess gene expression patterns and subcellular protein distributions with high resolution will vastly expand the number and quality of expression patterns of Drosophila genes.
Finally, both attP sites present in MiMIC can be used as docking sites for integration of gene targeting constructs 46 that can be used to engineer the genome in the vicinity of the transposon insertion. A collection of ~6,000 insertions spaced about 40 kilobases (kb) apart 5 should allow the manipulation of most genes by engineering and integrating large genomic constructs using the P[acman] system 47, 48 , recombineering methods 3 and RMCE 28 . ΦC31 integrase-mediated RMCE. Initial RMCE tests were performed with pBS-KS-attB1-2 to ensure functionality of the plasmid backbone, since this plasmid is the progenitor of all constructs for protein-trap cassettes and other cassettes. pBS-KS-attB1-2 DNA was purified and injected along with mRNA encoding ΦC31 integrase, obtained from pET11ΦC31pA (gift of M. Calos) 23 by in vitro transcription after BamHI linearization using the mMessage mMachine T7 kit as described previously 23, 47 . Microinjections were performed using the RMCE landing site 25C (gift of J. Bateman and T. Wu) 28 at a plasmid concentration of 123 ng µl −1 and an mRNA concentration of 600 ng µl −1 . A transgenesis efficiency of 17.5% was obtained.
Subsequent injections were performed with a transgenic ΦC31 integrase gene source driven by vasa promoter elements located on the X chromosome (y 1 M{vas-int.B}ZH-2A w*) (gift of J. Bischof, F. Karch and K. Basler) 24 . Plasmid was generally diluted to a concentration between 30 ng µl −1 and 100 ng µl −1 . Microinjections were performed using the following MiMIC insertion lines: Mi{MIC}tutl MI00290 and Mi{MIC}CadN MI00393 on chromosome 2, and Mi{MIC}Rfx MI00053 , Mi{MIC}gogo MI00065 , Mi{MIC}Tl MI00181 , Mi{MIC}caps MI00249 , Mi{MIC}rhea MI00296 , Mi{MIC}MYPT-75D MI00314 , Mi{MIC}BM-40-SPARC MI00329 , Mi{MIC}comm MI00380 and Mi{MIC}wnd MI00494 on chromosome 3. When lines contained a gene-trap insertion, they were injected as heterozygous balanced stocks. Microinjections were performed by crossing males from appropriate MiMIC lines to virgin females containing the ΦC31 integrase source. As RMCE results in a genetically unmarked chromosome owing to the removal of the y[+mDint2] marker, fly stocks were generated that contained the ΦC31 integrase source in a balanced background for the second or third chromosome to maintain the MiMIC insertion balanced in G 0 flies: y 1 M{vas-int. B}ZH-2A w*; noc Sco /CyO and y 1 M{vas-int.B}ZH-2A w*; Sb/TM6b, Hu, Tb. Appropriate G 0 flies were crossed to balancer virgins: y 1 w 67c23 ; In(2LR)Gla, wg Gla-1 /SM6a (BL6600) for chromosome 2 RMCE experiments, or y* w*; D/TM6b, Hu, Tb for chromosome 3 RMCE experiments. Transgenic G 1 flies were scored for the absence of a yellow + phenotype (loss of the y[+mDint2] marker) over a balancer or dominantly marked chromosome appropriate for the chromosome, and crossed to balancer virgins: y 1 w 67c23 ; In(2LR)Gla, wg Gla-1 /SM6a (BL6600) (chromosome 2), or y* w*; D/TM6b, Hu, Tb (chromosome 3). Balanced transgenic G 2 flies were intercrossed to establish stocks. A list with all RMCE efficiencies is available in Supplementary Table 6 .
Molecular characterization of integration events. For PCR verification of RMCE integration events, DNA was extracted customized P[acman] construct (K.J.T.V., unpublished data) and were analyzed as described below. QF swaps were crossed to y 1 w 1118 ; P{w +mC = QUAS-mtdTomato-3xHA}26 (BL30005) 30 and analyzed as described below. Flp swaps were crossed to a customized actin-GAL4-Flp-out line driving UAS-EGFP (H.J.B., unpublished data) and analyzed as described below.
Expression analysis. The following antibodies were used for expression analysis: mouse antibody to CadN (DN-Ex#8) at 1:200 (ref. 39 ; Developmental Studies Hybridoma Bank), rabbit antibody to RFX at 1:5,000 (gift from A. Laurençon and B. Durand) 40 , rabbit antibody to Wnd at 1:500 (gift from A. DiAntonio) 31 , rabbit antibody to GFP at 1:250 (Invitrogen), mouse antibody to DsRed at 1:250 (Clontech), rabbit antibody to TagRFP at 1:500 (Evrogen), rabbit antibody to Dendra2 at 1:5,000 (Evrogen), rabbit antibody to Killerred at 1:1,000 (Evrogen), mouse antibody to Flag at 1:250 (Sigma-Aldrich), mouse antibody to StrepII at 1:200 (Thermo Scientific), mouse antibody to the S epitope at 1:100 (Thermo Scientific), mouse anti-V5 at 1:2,000 (Invitrogen), mouse antibody to c-Myc at 1:250 (Abcam) and mouse antibody to the HA epitope at 1:200 (Covance).
Drosophila embryos (0-24 h) were collected on grape-agar plates and were subsequently fixed for 20 min in a 1:1 mixture of 0.38% formaldehyde in PBS (pH 7.0) and heptane. The fixative was then removed and methanol added. After vigorously shaking, the heptane-methanol mixture was replaced by methanol, and then methanol was replaced by ethanol. Upon rehydration in PBS with 0.2% Triton, embryos were blocked for 1 h in PBS, 10% normal goat serum and incubated overnight with primary antibodies. Fluorescently labeled or HRP-conjugated secondary antibodies were obtained from Jackson ImmunoResearch and were used at a 1:250 dilution. mRNA in situ hybridization. A 1-kb PCR fragment was obtained with primers Wnd-F and Wnd-R from the Wnd cDNA clone LD14856 78 and subcloned into the pGemTeasy vector (Promega). In vitro transcription was performed according to standard procedures, using the digoxigenin (DIG) RNA labeling kit (Roche). Fixation and in situ hybridization were carried out as previously described 79 . The digoxigenin-labeled RNA probes were detected by alkaline phosphatase reaction as previously described 80 .
